Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 18/20 | 0.52 |
| ▸ | PPARG | P37231 | 16/20 | 0.52 |
| ▸ | PPARD | Q03181 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5892186 | 0.89 | PPARG (0.45) | PPARAPPARGPPARD | |
| SCHEMBL4883401 | 0.88 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL4652672 | 0.85 | PPARG (0.54) | PPARAPPARGPPARD | |
| SCHEMBL4158540 | 0.81 | PPARG (0.49) | PPARAPPARGPPARD | |
| SCHEMBL5892164 | 0.79 | PPARA (0.54) | PPARAPPARGPPARD | |
| SCHEMBL4343679 | 0.78 | PPARG (0.45) | PPARAPPARGPPARD | |
| SCHEMBL7042474 | 0.77 | MEN1 (0.47) | PPARAPPARGPPARDSMN1; SMN2 | |
| SCHEMBL4755574 | 0.76 | PPARA (0.57) | PPARAPPARGPPARD | |
| SCHEMBL4653947 | 0.76 | PPARA (0.72) | PPARAPPARGPPARD | |
| SCHEMBL4758419 | 0.76 | PPARA (0.57) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090239917-A1 | Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them | LES LABORATOIRES SERVIER (FR) | 2009-09-24 | — | — | US | disclosed |
| US-20080113974-A1 | Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them. | LES LABORATOIRES SERVIER (FR) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080113974-A1 | Heterocyclic Oxime Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them. | CBR1, CYP3A7, CYP2C9 | PPARA 1634/4885PPARG 1185/4885PPARD 1308/4885 |
| US-20090239917-A1 | Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them | GPR119, LIPC, PNLIP | PPARA 462/4885PPARG 350/4885PPARD 572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.